These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27657350)

  • 1. Magnetic field therapy in patients with cytostatics-induced polyneuropathy: A prospective randomized placebo-controlled phase-III study.
    Rick O; von Hehn U; Mikus E; Dertinger H; Geiger G
    Bioelectromagnetics; 2017 Feb; 38(2):85-94. PubMed ID: 27657350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low frequency magnetic field therapy in patients with cytostatic-induced polyneuropathy: a phase II pilot study.
    Geiger G; Mikus E; Dertinger H; Rick O
    Bioelectromagnetics; 2015 Apr; 36(3):251-4. PubMed ID: 25644670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Acupuncture Treatment on Chemotherapy-Induced Peripheral Neuropathy: A Pilot, Randomized, Assessor-Blinded, Controlled Trial.
    Iravani S; Kazemi Motlagh AH; Emami Razavi SZ; Shahi F; Wang J; Hou L; Sun W; Afshari Fard MR; Aghili M; Karimi M; Rezaeizadeh H; Zhao B
    Pain Res Manag; 2020; 2020():2504674. PubMed ID: 32676134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy.
    Simpson DM; Rice AS; Emir B; Landen J; Semel D; Chew ML; Sporn J
    Pain; 2014 Oct; 155(10):1943-54. PubMed ID: 24907403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sweet bee venom pharmacopuncture for chemotherapy-induced peripheral neuropathy.
    Yoon J; Jeon JH; Lee YW; Cho CK; Kwon KR; Shin JE; Sagar S; Wong R; Yoo HS
    J Acupunct Meridian Stud; 2012 Aug; 5(4):156-65. PubMed ID: 22898064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of high tone therapy and transcutaneous electrical nerve stimulation therapy in chemotherapy-induced polyneuropathy.
    Schaffler-Schaden D; Sassmann R; Johansson T; Gampenrieder SP; Rinnerthaler G; Lampl K; Herfert J; Lenzhofer C; Landkammer YT; Rieder F; Greil R; Flamm M; Niebauer J
    Medicine (Baltimore); 2020 May; 99(19):e20149. PubMed ID: 32384502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of ranirestat in patients with mild-to-moderate diabetic sensorimotor polyneuropathy.
    Polydefkis M; Arezzo J; Nash M; Bril V; Shaibani A; Gordon RJ; Bradshaw KL; Junor RW;
    J Peripher Nerv Syst; 2015 Dec; 20(4):363-71. PubMed ID: 26313450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics and treatment of polyneuropathy developed after chemotherapy].
    Kholodova NB; Sotnikov VM; Dobrovol'skaia NIu; Ponkratova IuA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5):20-4. PubMed ID: 23739498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial - Protocol of a multicenter, randomized, double-blind, placebo- controlled proof-of-concept phase-2 clinical trial.
    Huehnchen P; Bangemann N; Lischewski S; Märschenz S; Paul F; Schmitz-Hübsch T; Blohmer JU; Eberhardt C; Rauch G; Flöel A; Adam S; Schwenkenbecher P; Meinhold-Heerlein I; Hoffmann O; Ziemssen T; Endres M; Boehmerle W
    Front Med (Lausanne); 2022; 9():967964. PubMed ID: 36035422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulsed magnetic field therapy in refractory neuropathic pain secondary to peripheral neuropathy: electrodiagnostic parameters--pilot study.
    Weintraub MI; Cole SP
    Neurorehabil Neural Repair; 2004 Mar; 18(1):42-6. PubMed ID: 15035963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and electromyography characteristics of chemotherapy-induced polyneuropathy].
    Kholodova NB; Ponkratova YA; Sinkin MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):59-66. PubMed ID: 29053122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lenalidomide in patients with chemotherapy-induced polyneuropathy and relapsed or refractory multiple myeloma: results from a single-centre prospective study.
    Briani C; Torre CD; Campagnolo M; Lucchetta M; Berno T; Candiotto L; Padua L; Ermani M; Cavaletti G; Zambello R
    J Peripher Nerv Syst; 2013 Mar; 18(1):19-24. PubMed ID: 23521639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.
    Davis ID; Kiers L; MacGregor L; Quinn M; Arezzo J; Green M; Rosenthal M; Chia M; Michael M; Bartley P; Harrison L; Daly M
    Clin Cancer Res; 2005 Mar; 11(5):1890-8. PubMed ID: 15756015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rehabilitation methods for cancer patients with peripheral polyneuropathy induced by cytostatics].
    Grushina TI; Konchugova TV; Kulchitskaya DB; Gushchina NV; Astakhova KA
    Vopr Kurortol Fizioter Lech Fiz Kult; 2021; 98(1):58-63. PubMed ID: 33605131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3.
    Rao RD; Flynn PJ; Sloan JA; Wong GY; Novotny P; Johnson DB; Gross HM; Renno SI; Nashawaty M; Loprinzi CL
    Cancer; 2008 Jun; 112(12):2802-8. PubMed ID: 18428211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of ubiquinone in diabetic polyneuropathy: a randomized double-blind placebo-controlled study.
    Hernández-Ojeda J; Cardona-Muñoz EG; Román-Pintos LM; Troyo-Sanromán R; Ortiz-Lazareno PC; Cárdenas-Meza MA; Pascoe-González S; Miranda-Díaz AG
    J Diabetes Complications; 2012; 26(4):352-8. PubMed ID: 22595020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial.
    Gilron I; Wajsbrot D; Therrien F; Lemay J
    Clin J Pain; 2011; 27(3):185-93. PubMed ID: 21178603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent cyclophosphamide with prednisone versus placebo for polyneuropathy with IgM monoclonal gammopathy.
    Niermeijer JM; Eurelings M; van der Linden MW; Lokhorst HM; Franssen H; Fischer K; Teunissen LL; van den Berg LH; Schobben F; Wokke JH; Notermans NC
    Neurology; 2007 Jul; 69(1):50-9. PubMed ID: 17606880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.